Veterinary Medicines Information website

Vanguard Plus 7 vakcina A.U.V.

Authorised
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
  • Leptospira interrogans, serovar Canicola, strain C51, Inactivated
  • Canine parvovirus, strain NL-35-D, Live
  • Canine parainfluenza virus, strain NL-CPI-5, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine distemper virus, Live
Download as PDF

Product identification

Medicine name:
Vanguard Plus 7 vakcina A.U.V.
Active substance:
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
  • Leptospira interrogans, serovar Canicola, strain C51, Inactivated
  • Canine parvovirus, strain NL-35-D, Live
  • Canine parainfluenza virus, strain NL-CPI-5, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine distemper virus, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
    40.00
    log10 50% cell culture infectious dose
    /
    1.00
    unit(s)/dose
  • Leptospira interrogans, serovar Canicola, strain C51, Inactivated
    40.00
    log10 50% cell culture infectious dose
    /
    1.00
    unit(s)/dose
  • Canine parvovirus, strain NL-35-D, Live
    7.00
    log10 50% cell culture infectious dose
    /
    1.00
    unit(s)/dose
  • Canine parainfluenza virus, strain NL-CPI-5, Live
    6.00
    log10 50% cell culture infectious dose
    /
    1.00
    unit(s)/dose
  • Canine adenovirus 2, strain Manhattan, Live
    3.20
    log10 50% cell culture infectious dose
    /
    1.00
    unit(s)/dose
  • Canine distemper virus, Live
    3.00
    log10 50% cell culture infectious dose
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Powder and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Available in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Hungary Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change: